ABO Blood Groups, Rh Factor, and Thyroid Cancer Risk: To ‘B’ or Not to ‘B’

References

• He LZ, Zeng TS, Pu L, Pan SX, Xia WF, Chen LL. Thyroid hormones, autoantibodies, ultrasonography, and clinical parameters for predicting thyroid cancer. Int J Endocrinol. 2016;2016:8215834. doi:10.1155/2016/8215834.
   PubMedGoogle Scholar
• Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–2167. doi:10.1001/jama.295.18.2164.
   PubMed Web of Science ®Google Scholar
• Verkooijen HM, Fioretta G, Pache JC, et al. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control. 2003;14:13–17. doi:10.1023/A:1022593923603.
   PubMed Web of Science ®Google Scholar
• Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212. doi:10.1155/2013/965212.
   PubMedGoogle Scholar
• Cao Y, Wang Z, Gu J, et al. Reproductive factors but not hormonal factors associated with thyroid cancer risk: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:103515. doi:10.1155/2015/103515.
   PubMedGoogle Scholar
• Fei X, Yang D, Kong Z, Lou Z, Wu J. Thyroid cancer incidence in China between 2005 and 2009. Stochastic Environ Res Risk Ass. 2014;28:1075–1082. doi:10.1007/s00477-014-0876-5.
   Web of Science ®Google Scholar
• Dal Maso L, Bosetti C, La Vecchia C, Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control. 2009;20:75–86. doi:10.1007/s10552-008-9219-5.
   PubMed Web of Science ®Google Scholar
• McLeod DS, Cooper DS, Ladenson PW, et al. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. Thyroid. 2014;24:35–42. doi:10.1089/thy.2013.0062.
   PubMed Web of Science ®Google Scholar
• Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol. 2008;15:1518–1522. doi:10.1245/s10434-008-9859-4.
   PubMed Web of Science ®Google Scholar
• Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus. 2016;14:434–440. doi:10.2450/2015.0164-15.
   PubMed Web of Science ®Google Scholar
• Liumbruno GM, Franchini M. Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolys. 2014;38:160–166. doi:10.1007/s11239-013-1027-4.
   PubMed Web of Science ®Google Scholar
• Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus. 2013;11:491–499. doi:10.2450/2013.0152-13.
   PubMed Web of Science ®Google Scholar
• Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1953;1:799–801. doi:10.1136/bmj.1.4814.799.
   PubMed Web of Science ®Google Scholar
• Franchini M, Liumbruno GM. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med. 2013;51:1545–1553. doi:10.1515/cclm-2013-0168.
   PubMed Web of Science ®Google Scholar
• Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010;172:1280–1285. doi:10.1093/aje/kwq299.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu L, Ji J, et al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci. 2012;13:13308–13321. doi:10.3390/ijms131013308.
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Chan AT, Hartge P, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst. 2009;101:424–431. doi:10.1093/jnci/djp020.
   PubMed Web of Science ®Google Scholar
• Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol. 2004;41:93–117. doi:10.1053/j.seminhematol.2004.01.001.
   PubMed Web of Science ®Google Scholar
• Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta. 1999;1473:247–266. doi:10.1016/S0304-4165(99)00183-X.
   PubMed Web of Science ®Google Scholar
• Zhang BL, He N, Huang YB, Song FJ, Chen KX. ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2014;15:4643–4650. doi:10.7314/APJCP.2014.15.11.4643.
   PubMedGoogle Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867. doi:10.1038/nature01322.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–444. doi:10.1038/nature07205.
   PubMed Web of Science ®Google Scholar
• Barbalic M, Dupuis J, Dehghan A, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 2010;19:1863–1872. doi:10.1093/hmg/ddq061.
   PubMed Web of Science ®Google Scholar
• Paré G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008;4:e1000118. doi:10.1371/journal.pgen.1000118.
   PubMed Web of Science ®Google Scholar
• Vasan SK, Hwang J, Rostgaard K, et al. ABO blood group and risk of cancer: a register‐based cohort study of 1.6 million blood donors. Cancer Epidemiol. 2016;44:40–43. doi:10.1016/j.canep.2016.06.005.
   PubMed Web of Science ®Google Scholar
• Gong Y, Yang YS, Zhang XM, et al. ABO blood type: diabetes and risk of gastrointestinal cancer in Northern China. World J Gastroenterol. 2012;18:563–569. doi:10.3748/wjg.v18.i6.563.
   PubMed Web of Science ®Google Scholar
• Zivaljevic V, Slijepcevic N, Paunovic I, et al. Risk factors for anaplastic thyroid cancer. Int J Endocrinol. 2014;2014:815070.
   PubMedGoogle Scholar
• Szulman AE. The histological distribution of the blood group substances in man as disclosed by immunofluorescence III. The A, B, and H antigens in embryos and fetuses from 18 mm in length. J Exp Med. 1964;119:503–516. doi:10.1084/jem.119.4.503.
   PubMed Web of Science ®Google Scholar
• González-Cámpora R, Gracía-Santana JA, Jorda i Heras MM, et al. Blood group antigens in differentiated thyroid neoplasms. Arch Pathol Lab Med. 1998;122:957–965.
   PubMed Web of Science ®Google Scholar
• Vowden P, Lowe AD, Lennox ES, Bleehen NM. Thyroid blood group isoantigen expression: a parallel with ABH isoantigen expression in the distal colon. Br J Cancer. 1986;53:721–725. doi:10.1038/bjc.1986.124.
   PubMed Web of Science ®Google Scholar
• Rummel SK, Ellsworth RE. The role of the histoblood ABO group in cancer. Future Sci OA. 2016;2:FSO107. doi:10.4155/fsoa-2015-0012.
   PubMed Web of Science ®Google Scholar
• Stamatakos M, Kontzoglou K, Safioleas P, Safioleas C, Manti C, Safioleas M. Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor. Int Semin Surg Oncol. 2009;6:14. doi:10.1186/1477-7800-6-14.
   PubMedGoogle Scholar
• Schulze AB, Schmidt LH, Baie L, et al. Rhesus CE expression on patient red blood cells is an independent prognostic factor for adenocarcinoma of the lung. Clin Respir J. 2017. doi:10.1111/crj.12638.
   PubMed Web of Science ®Google Scholar
• Süer E, Özcan C, Gökce I, et al. Do blood groups have effect on prognosis of patients undergoing radical cystectomy? Int Urol Nephrol. 2014;46:1521–1526. doi:10.1007/s11255-014-0698-x.
   PubMed Web of Science ®Google Scholar
• Miao SY, Zhou W, Chen L, Wang S, Liu XA. Influence of ABO blood group and Rhesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244,768 controls. Asia Pac J Clin Oncol. 2014;10:101–108. doi:10.1111/ajco.12083.
   PubMed Web of Science ®Google Scholar
• Tashiro R, Niizuma K, Khor SS, et al. Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: a case-control study. Plos One. 2019;14:e0220858. doi:10.1371/journal.pone.0220858.
   PubMed Web of Science ®Google Scholar
• Shuxian J, Xiaoyun C, Zhihui F, et al. Association of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas. Thyroid. 2014;24:867–871. doi:10.1089/thy.2013.0130.
   PubMed Web of Science ®Google Scholar
• Ben Q, Wang K, Yuan Y, Li Z. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case‐control study. Int J Cancer. 2011;128:1179–1186. doi:10.1002/ijc.25426.
   PubMed Web of Science ®Google Scholar
• Dall’olio F. Protein glycosylation in cancer biology: an overview. Clin Mol Pathol. 1996;49:M126–135. doi:10.1136/mp.49.3.M126.
   PubMedGoogle Scholar
• Gao S, Worm J, Guldberg P, et al. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer. 2004;109:230–237. doi:10.1002/ijc.11592.
   PubMed Web of Science ®Google Scholar
• Zhou J, Yang LC, He ZY, Li FY, Wu SG, Sun JY. Prognostic impact of AB0 blood group on the survival in patients with ovarian cancer. J Cancer. 2015;6:970–975. doi:10.7150/jca.12471.
   PubMed Web of Science ®Google Scholar